244
Views
46
CrossRef citations to date
0
Altmetric
Editorial

Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairments

, , &
Pages 683-686 | Published online: 10 May 2005

Bibliography

  • BECKERS T, MAHBOOBI S: Natural, semi-synthetic and synthetic microtubule inhibitors for cancer therapy. Drugs of the Future (2003) 28:767–785.
  • BIABANI MF, GUNASEKERA SP, LONGLEY RE, WRIGHT AE, POMPONI SA: Tubercidin, a cytotoxic agent from the marine sponge Caulospongia Pharmaceut. Biol. (2002) 40:302–303.
  • BRITTON R, DILIP DE SILVA E, BIGG CM, MCHARDY LM, ROBERGE M, ANDERSEN RJ: Synthetic transformations of eleutherobin reveal new features of its microtubule-stabilizing pharmacophore. J. Amer. Chem. Soc (2001) 123:8632–8633.
  • CHEN J.-G, HORWITZ SB: Differentialmitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res. (2002) 62:1935–1938.
  • FORMAN MS, TROJANOWSKI JQ, LEE VM-Y: Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. (2004) 10:1055–1063.
  • GAITANOS TN, BUEY, RIVI, DIAZ JF et al.: Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res. (2004) 64:5063–5067.
  • GAPUD, EJ, BAT R, GHOSK AK, HAMEL E: Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously. Molec. Pharmacol (2004) 66:113–121.
  • GOODIN S, KANE MP, RUBIN EH: Epothilones: mechanism of action and biologic activity.' Clin. Oncol (2004) 22:2015–2025.
  • GUZIK BW, GOLDSTEIN LS: Microtubule-dependent transport in neurons: steps towards an understanding of regulation, function and dysfunction. Curr. Opin. Cell. Biol. (2004) 16:443–450.
  • HAMEL E, SACKETT DL, VOURLOUMIS D, NICOLAOU KC: The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochem. (1999) 38:5490–5498.
  • HE L, ORR GA, HORWITZ SB: Novel molecules that interact with microtubules and have functional activity similar to Taxol. Drug Discov. Today (2001) 6:1153–1164.
  • HIGUCHI M, LEE VM-Y, TROJANOWSKI, JQ: Tau and axonopathy in neurodegenerative disorders. NeuroMolec. Med. (2002) 2:131–150.
  • ISBRUCKER RA, CUMMINS J, POMPONI SA, LONGLEY RE, WRIGHT AE: Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin. Biochem. Pharmacol (2003) 66:75–82.
  • LEE VM-Y, DAUGHENBAUGH R, TROJANOWSKI JQ: Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging (1994) 15:S87–S89.
  • MADARI H, PANDA D, WILSON L, JACOBS RS: Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with taxol. Cancer Res. (2003) 63:1214–1220.
  • MANI S, MACAPINLAC M, GOEL S et al: The clinical development of new mitotic inhibitors that stabilize the microtubule. Anticancer Drugs (2004) 15:553–558.
  • MATRELLO LA, MCDAID HM, REGL DL et al.: Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin. Cancer Res. (2000) 6:1978–1987.
  • MICHAELIS ML, ANSAR S, CHEN Y et al.: Beta-amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J. Pharmacol Exp. Ther. (2005) 312:659–668.
  • •This paper describes how paclitaxel protects against 13-amyloid toxicity.
  • MOOBERRY SL, RANDALL- HLUBEK DA, LEAL RIVI et al: Microtubule-stabilizing agents based on designed laulimalide analogues. Proc. Natl. Acad. Sci.USA (2004) 101:8803–8808.
  • MYLES DC: Emerging microtubule stabilizing agents for cancer chemotherapy. Ann. Reports Med. Chem. (2002) 37:125–132.
  • NORA DE SOUZA MV: New natural products able to act on the stabilization of microtubules, an important target against cancer. Quimica Nova (2004) 27:308–312.
  • OJIMA I, CHAKRAVARTY S, INOUE T et al: A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc. Natl. Acad. Sci. USA (1999) 96:4256–4261.
  • PODBIELKOWSKA M, PIWOCKA M, WASZKOWSKA E, WALEZA M, ZOBEL AM: Effect of coumarin and its derivatives on mitosis and ultrastructure of meristematic cells. Internatl. I Pharm. (1995) 33:7–15.
  • RICE A, LIU Y, MICHAELIS ML, HIMES RH, GEORG GI, AUDUS KL: Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ. J. Med Chem. (2005) 48:832–838.
  • •This paper describes a modified derivative of paclitaxel that penetrates the blood-brain barrier more effectively than its parent compound.
  • ROY S, ZHANG B, LEE VM-Y, TROJANOWSKI JQ: Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol (2005) 109:5–13.
  • SMITH AB 3rd, FREEZE BS, LAMARCHE MJ et al: Design, synthesis, and evaluation of carbamate-substituted analogues of (+)-discodermolide. Org. Lett. (2005) 7:311–314.
  • STACHEL SJ, BISWAS K, DANISHEFSKY SJ: The epothilones, eleutherobins, and related types of molecules. Curr. Pharm. Design, (2001) 7:1277–1290.
  • TINLEY, TL, RANDALL-HLUBEK DA, LEAL RIVI et al.: Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity. Cancer Res. (2003) 63:3211–3220.
  • ZHANG B, MAITI A, SHIVELY S et al:Microtubule binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a murine neurodegenerative tauopathy model. Proc. Natl. Acad. Li. USA (2005)102.227231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.